Published in Am J Pathol on February 01, 1994
ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics (2009) 1.26
MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Am J Pathol (1996) 0.95
Double immunohistochemical staining method for HIF-1alpha and its regulators PHD2 and PHD3 in formalin-fixed paraffin-embedded tissues. Appl Immunohistochem Mol Morphol (2010) 0.83
Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts. Br J Cancer (1997) 0.78
P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Br J Cancer (1996) 0.78
Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate. Invest New Drugs (2002) 0.75
Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet (1985) 3.23
Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol (1990) 2.88
Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem (1990) 2.86
Aminoalkylsilane-treated glass slides as support for in situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditions. Histochem J (1986) 2.49
P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med (1991) 2.32
Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol (1990) 2.20
How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res (1993) 2.04
Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance. Int J Cancer (1988) 1.78
Expression of a multidrug resistance gene in esophageal adenocarcinoma. Correlation with response to chemotherapy and comparison with gastric adenocarcinoma. Am J Clin Pathol (1990) 1.50
Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res (1987) 1.49
Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res (1991) 1.40
P-glycoproteins in pathology: the multidrug resistance gene family in humans. Hum Pathol (1990) 1.27
Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res (1991) 1.25
P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Blood (1993) 1.16
A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines. Lab Invest (1988) 1.07
Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Res (1993) 0.99
Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma. Am J Pathol (1991) 0.98
Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis. J Histochem Cytochem (1991) 0.96
Immunohistochemical analysis of pulmonary and pleural tumors with the monoclonal antibody HYB-612 directed against the multidrug resistance (MDR-1) gene product, P-glycoprotein. Tumour Biol (1989) 0.89
Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies. Lab Invest (1990) 0.89
P-glycoprotein expression is increased in human secretory and gestational endometrium. Lab Invest (1991) 0.87
Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas. Histopathology (1991) 0.87
Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines. J Natl Cancer Inst (1992) 0.86
Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinoma. Mod Pathol (1990) 0.84
Expression and functions of P-glycoprotein (mdr1 gene product) in normal and malignant tissues. Acta Pathol Jpn (1990) 0.83
Detection of P-glycoprotein with JSB-1 monoclonal antibody in B-5 fixed and paraffin-embedded cell lines and tissues. Sel Cancer Ther (1991) 0.80
Comparison of an immunoperoxidase "sandwich" staining method and western blot detection of P-glycoprotein in human cell lines and sarcomas. Am J Pathol (1992) 0.78
P-glycoprotein expression in gastroesophageal adenocarcinomas, their metastases, and surrounding mucosa: a mapping study. Mod Pathol (1991) 0.78
Histologic observations and P-glycoprotein expression in gastric and esophageal adenocarcinomas treated with preoperative chemotherapy. Arch Pathol Lab Med (1991) 0.78
Effects of nutrient deprivation on Vibrio cholerae. Appl Environ Microbiol (1983) 3.78
Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res (1990) 3.24
Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. Cancer J Sci Am (2006) 2.68
Isolation of mutants of cultured mammalian cells. Methods Cell Biol (1973) 1.95
The changing histopathology of lung cancer: a review of 1682 cases. Cancer (1977) 1.72
Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol (1996) 1.70
P-glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol (1987) 1.64
Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP) Ann Oncol (1997) 1.63
Isolation of ouabain-resistant human diploid fibroblasts. Cell (1974) 1.55
Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem (1997) 1.52
Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol (2001) 1.50
Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma. J Natl Cancer Inst (1996) 1.49
Effect of postoperative empyema on survival of patients with bronchogenic carcinoma. J Thorac Cardiovasc Surg (1970) 1.44
Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler. Ultrasound Obstet Gynecol (2015) 1.43
Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibody. Cancer Res (1988) 1.43
Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin. Cancer (1972) 1.37
Ultrasonic surgical aspirator for lung resection. Ann Thorac Surg (1991) 1.37
Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J Bone Joint Surg Am (2001) 1.36
Isolation of temperature-sensitive mutants of L-cells. Proc Natl Acad Sci U S A (1970) 1.34
Primary tumors of the mediastinum. J Surg Oncol (1999) 1.29
Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest (1994) 1.27
Selective and nonselective isolation of temperature-sensitive mutants of mouse L-cells and their characterization. J Cell Physiol (1971) 1.25
Growth factor-loaded scaffolds for bone engineering. J Control Release (2005) 1.25
Ouabain as a selective agent in the isolation of somatic cell hybrids. Cytogenet Cell Genet (1975) 1.20
Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies. N Engl J Med (1983) 1.19
Resident preferences for the clinical teaching of ambulatory care. J Med Educ (1982) 1.19
BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. J Biomed Mater Res (1998) 1.19
Lung resection for metastatic sarcoma. Am J Surg (1978) 1.18
HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. Lab Invest (1998) 1.17
Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. Cancer Res (1980) 1.17
Changes in ribo- and deoxyribonucleoside triphosphate pools within the cell cycle of a synchronized mouse fibroblast cell line. Biochim Biophys Acta (1983) 1.16
Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis. Oncogene (2000) 1.14
Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas. Cancer Res (1982) 1.14
Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer. Br J Cancer (2000) 1.13
Phase I clinical trial of recombinant human tumor necrosis factor. Cancer Chemother Pharmacol (1987) 1.12
Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. Cancer Res (1976) 1.12
Surgical management of adrenal metastases from lung cancer. J Surg Oncol (1998) 1.11
Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors. Cytometry (1984) 1.11
Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology (1995) 1.11
Dissociation of yeast hexokinase under the influence of substrates. Biochemistry (1972) 1.11
Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency. Cancer Res (1987) 1.10
Modeling of the time-dependency of in vitro drug cytotoxicity and resistance. Cancer Res (1998) 1.09
Surgical therapy of lung cancer. J Thorac Cardiovasc Surg (1976) 1.07
Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study. Ann Oncol (2003) 1.07
Membrane-associated glycoprotein (gp 160) identified on human lung tumors by a monoclonal antibody. Cancer Res (1986) 1.07
Super in vitro synergy between inhibitors of dihydrofolate reductase and inhibitors of other folate-requiring enzymes: the critical role of polyglutamylation. Cancer Res (1998) 1.06
Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology (1997) 1.05
Resection of lung metastases from soft-tissue sarcomas. A multivariate analysis. Arch Surg (1992) 1.04
Comparison of 5-fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer. Eur J Cancer (1998) 1.04
A case of fatal infectious mononucleosis presenting with fulminant hepatic failure associated with an extensive CD8-positive lymphocyte infiltration in the liver. Hum Pathol (1993) 1.02
Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer. J Clin Oncol (1999) 1.02
A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. J Clin Oncol (1987) 1.01
Dominance of colchicine resistance in hybrid CHO cells. Somatic Cell Genet (1978) 1.01
Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage. Breast Cancer Res Treat (1996) 1.00
Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat (1997) 1.00
Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose. Cancer Res (2000) 0.99
Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry. Cytometry (1984) 0.99
Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells. J Histochem Cytochem (2000) 0.99
Metastasectomy in malignant melanoma. Surgery (1994) 0.99
Growth of cell colonies in soft agar from biopsies of different human solid tumors. Cancer Res (1980) 0.98
Yeast Hexokinase. IV. Multiple forms of hexokinase in the yeast cell. Biochemistry (1971) 0.98
Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38. J Natl Cancer Inst (1987) 0.98
Herniation of the heart following intrapericardial pneumonectomy. Report of a case and review. J Thorac Cardiovasc Surg (1970) 0.97
Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck. Am J Surg (1992) 0.96
Selection of mutant Chinese hamster ovary cells altered glycoproteins by means of tritiated fucose suicide. Mol Cell Biol (1981) 0.96
Modulated expression of type X collagen in Meckel's cartilage with different developmental fates. Dev Biol (1995) 0.96
Water drinking induced in sheep by angiotensin--a physiological or pharmacological effect? J Comp Physiol Psychol (1975) 0.96
Sentinel node biopsy in breast cancer. Ann Surg Oncol (1998) 0.96
Failure of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate to enhance sister chromatid exchange, mitotic segregation, or expression of mutations in Chinese hamster cells. Cancer Res (1980) 0.96
Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture. Cancer Res (1979) 0.96
Colony growth in soft agar of human melanoma, sarcoma, and lung carcinoma cells disaggregated by mechanical and enzymatic methods. Cancer Res (1980) 0.96
Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy. Cancer Res (1979) 0.96
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux. Cytometry (1996) 0.96
Chemosensitivity to triazene compounds and O6-alkylguanine-DNA alkyltransferase levels: studies with blasts of leukaemic patients. Ann Oncol (1995) 0.96
Small cell carcinoma of the lung. Clinicopathological studies. J Thorac Cardiovasc Surg (1973) 0.95
PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein. Clin Cancer Res (1996) 0.95
Childhood transient erythroblastopenia complicated by thrombocytopenia and neutropenia. Eur J Haematol (1989) 0.95
Characterization of cells obtained by mechanical and enzymatic means from human melanoma, sarcoma, and lung tumors. Cancer Res (1981) 0.95
Yeast hexokinase. V. Subunit structure and hybridization of isoenzymes. Biochemistry (1971) 0.95
MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Am J Pathol (1996) 0.95
Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res (1984) 0.95
Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation. J Biomed Mater Res (2000) 0.95
DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. Cancer Res (1996) 0.94
HeLa cell variants that differ in sensitivity to monofunctional alkylating agents, with independence of cytotoxic and mutagenic responses. Proc Natl Acad Sci U S A (1979) 0.94